COMMUNIQUÉS West-GlobeNewswire

Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea et Ionis annoncent l’homologation de TEGSEDIMC (inotersen pour injection) au Canada
04/10/2018
Le premier et le seul traitement de ce type pour les Canadiens atteints d’amylose héréditaire liée à la transthyrétine (hATTR) avec polyneuropathie, une maladie héréditaire rare OTTAWA et BOSTON et CARLSBAD, Californie [...]
Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
04/10/2018
PITTSBURGH, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Allscripts and Appriss Health Partner to Provide Access to Prescription Drug Monitoring Program Information and the NarxCare Substance Use Disorder Platform
04/10/2018
Integration will enable Allscripts ePrescribe and EHR users to gain access to critical information and insights within clinical workflows; improves patient safety and outcomes through Appriss Health’s PMP Gateway [...]
Paratek Announces Acceptance of European Marketing Authorization Application for Oral and Intravenous Omadacycline
04/10/2018
-- MAA submission for both community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) -- -- EMA decision expected second half of 2019 -- BOSTON, Oct. 04, 2018 (GLOBE [...]
Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants
04/10/2018
WALTHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced that it intends to offer and sell shares [...]
AVROBIO, Inc. to Present at Chardan's 2nd Annual Genetic Medicines Conference
04/10/2018
CAMBRIDGE, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company developing gene therapies to potentially cure rare diseases with a single [...]
Chris Swanker Receives NADP Gabryl Award
04/10/2018
National Lifetime Achievement Award Honors Contributions to Dental Benefits Industry DALLAS, Oct. 04, 2018 (GLOBE NEWSWIRE) -- For his leadership during critical health care reform years, Chris Swanker, Chief Executive [...]
Alpha II Will Join Health Care Leaders from Across the Globe at Cerner Health Conference 2018
04/10/2018
Healthcare conference will host nearly 14,000 in Kansas City, Oct. 8-11 TALLAHASSEE, Fla., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of software-as-a-service (SaaS) solutions that support [...]
Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
04/10/2018
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) ( CSE: ATT ) ( OTC: ATTBF ) is pleased to announce that the research being done in conjunction [...]
Acasti Pharma Prices C$24 Million Underwritten Offering
04/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”) is pleased [...]
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
04/10/2018
MONTREAL, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
The Ensign Group Acquires Nevada Senior Housing Facility
04/10/2018
MISSION VIEJO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
BrainStorm Poster Receives Clinical Abstract Award at NEALS Conference
04/10/2018
Translational Insights Support NurOwn ® as a Best-In-Class Strategy in ALS NEW YORK and PETACH TIKVAH, Israel, Oct. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of [...]
Trident Brands Inc. Signs Canadian Distribution Agreement for Their Brain Armor Brand with Peak Performance Products Inc.
04/10/2018
Brookfield, WI, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB:TDNT), a biotech and nutraceutical company structured to rapidly develop private label, control label, brand label and [...]
MannKind Presents Positive Afrezza® STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes
04/10/2018
Poster 813; PS 068 Improved post-prandial blood glucose excursions with Technosphere inhaled insulin compared to aspart in adult patients with type 1 diabetes: STAT study intention to treat analysis Poster 677; PS 051 [...]
eTrueNorth Launches National Voucher Solution Program Enabling Wellness Screenings at Retail Pharmacies
04/10/2018
Local retail pharmacies accept eLabNetwork® vouchers and provide wellness screenings FORT WORTH, Texas, Oct. 04, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the premier integrated pharmacy-based clinical services network, has [...]
Predictive Diagnostics Launches Endometriosis Risk Test
04/10/2018
SALT LAKE CITY, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification enabling revolutionary therapeutic approaches, [...]

Pages